Alternate-day steroids in paedriatric renal transplantation;Esteroides en días alternos en trasplante renal pediátrico

Revista Chilena de Pediatria

Volumn 72, Issue 5, 2001, Pages 416-424

  Villagra, Jorge C ^a   Cano, Francisco Sch ^a   Delucchi, Angela B ^a   Rodríguez, Eugenio S ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Alternate day prednisone; Growth; Renal transplant; Steroids

Indexed keywords

CREATINE; PREDNISONE; STEROID;

ACADEMIC ACHIEVEMENT; ADOLESCENT; AGE; ARTICLE; BODY HEIGHT; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; SOCIOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; UREMIA;

EID: 0035685779     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. A decade of living donor transplantation in North American Children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study
2. Trasplante renal pediátrico en Chile, Estudio multicéntrico
3. Outcome and growth of infants with severe chronic renal failure
4. A longitudinal study of the natural history of growth posttrasplantation
5. Growth post renal-transplantation in children: Lessons from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
6. The 12th annual report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998
7. Cognitive development and learning in the pediatric organ transplant recipient
8. Do children exhibit catch-up growth post transplant: North American Pediatric Renal Transplant Cooperative Study special study
9. Growth rates in pediatric dialysis patients and renal transplant recipients
10. Final height and its predictive factors after renal transplantation in childhood
11. Outcome of renal transplantation in children less than two years of age
12. Outcome of renal transplantation in children aged 1-5 and 6-18 years
13. Kidney transplanted children come of age
14. Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation
15. Pediatric renal transplantation from the early 1970's through the cyclosporine years at Policlinico University Hospital of Milan
16. Growth after renal transplantation: Correlation with immunosupressive therapy
17. Glucose tolerance in children with renal allografts and effect of growth hormone treatment
18. Growth after conversion to alternate-day corticosteroids in children with renal transplans: A single-center study
19. Factors affecting growth and strategies for treatment in children after renal transplantation
20. Value of bone densitometry in pediatric renal transplantation
21. A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine
22. Selected prognostic factors of long-term renal graft function
23. Tacrolimus in pediatric renal transplantation
24. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation
25. Growth rate in children receiving alternate day corticosteroid treatment after kidney transplantation
26. Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation
27. Challenges after pediatric transplantation
28. Renal transplantation and chronic dialysis in children and adolescents: The 1993 annual report of the North American Pediatric Renal Transplant Cooperative Study
29. The 1997 annual renal transplantation in children report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
30. Report on management of renal failure in europe, XXV, 1994. The child-adult interfase
31. Effect of deflazacort versus methylprednisolone on growth, body composition, lipid profile, and bone mass after renal transplantation
32. The impact of recombinant human growth hormone treatment on final adult height